Grundet risikoen for alvorlige reaktioner overfor de to aktive stoffer hos ammende nyfødte, bør der der tages en beslutning om hvorvidt amning eller behandling bør ophøre, med hensyntagen til vigtigheden af denne behandling for moderen.
Because of the potential for serious reactions in nursing infants from both active substances, a decision should be made whether to discontinue nursing or to discontinue therapy taking account of the importance of this therapy to the mother.